Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBM Plans For Medicare Should Wait Until After Election – Scully

Executive Summary

Health plans and pharmacy benefit management companies should hold off on making a decision about offering a stand-alone drug plan until after the November elections, former Centers for Medicare & Medicaid Services Administrator Tom Scully recommended

You may also be interested in...



Medco Plans For Part D Will Be Formed After Election Day

Medco believes there may be ways to make the private drug insurance model attractive to pharmacy benefit management companies - but does not expect the issue to be resolved until after the elections

Medco Plans For Part D Will Be Formed After Election Day

Medco believes there may be ways to make the private drug insurance model attractive to pharmacy benefit management companies - but does not expect the issue to be resolved until after the elections

Senate Drug Importation Debate May Be Pushed Back To Fall

A Senate debate on drug reimportation legislation appears on track to be pushed back until the fall

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel